A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age-Reference-Cited by-同舟云学术

A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age

Published:2015-04-08 Issue:3 Volume:170 Page:349-355
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Buckley Sarah A.¹²,Mawad Raya¹²,Gooley Ted A.¹²,Becker Pamela S.¹²,Sandhu Vicky¹,Hendrie Paul¹²,Scott Bart L.¹²,Wood Brent L.¹³,Walter Roland B.¹²,Smith Kelly¹²,Dean Carol¹,Estey Elihu H.¹²,Pagel John M.¹²

Affiliation:

1. Division of Clinical Research; Fred Hutchinson Cancer Research Center; Seattle WA USA

2. Department of Medicine; University of Washington; Seattle WA USA

3. Department of Laboratory Medicine; University of Washington; Seattle WA USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13437/fullpdf

Reference14 articles.

1. Age and acute myeloid leukemia;Appelbaum;Blood,2006

2. Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival;Burnett;Blood,2013

3. Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy;Doubek;Neoplasma,2005

4. Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias;Faderl;Blood,2005

5. A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome;Faderl;Blood,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical Donor Transplantation Using a Novel Clofarabine-containing Conditioning Regimen for Very High-risk Hematologic Malignant Neoplasms;Journal of Pediatric Hematology/Oncology;2018-11

2. A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia;Leukemia & Lymphoma;2017-07-18

3. Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma;Clinical Cancer Research;2017-04-25

4. Clinical Use of Clofarabine for Adults and Children with Leukemia;Chemotherapy for Leukemia;2017

5. Clofarabine: Structure, Mechanism of Action, and Clinical Pharmacology;Chemotherapy for Leukemia;2017